Company / Cost of Revenue
Outset Medical, Inc. Cost of Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$101.4M
FY2025
5-year range
$32.9M / $101.4M
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 5 consecutive years, from $8M in FY2020 to $101M in FY2025.
Based on SEC 10-K filings.
$101M in FY2025 with a 5-year CAGR of +65.7%.
Increased from $95M to $101M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- +65.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Outset Medical, Inc.'s cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +65.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 3.9% year-over-year.
- Lowest cost of revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $101.4M | +3.9% |
| FY2024 | $97.5M | +2.7% |
| FY2023 | $95.0M | +50.9% |
| FY2022 | $63.0M | +91.5% |
| FY2021 | $32.9M | +304.8% |
| FY2020 | $8.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026